@aclarioninc Avatar @aclarioninc Aclarion

Aclarion posts on X about $acon, nasdaq, ceo, adoption the most. They currently have [---] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.

Engagements: [--] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [---] #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence stocks 61.29% exchanges 9.68% finance 6.45% travel destinations 6.45%

Social topic influence $acon #4, nasdaq 32.26%, ceo 19.35%, adoption 12.9%, in the 12.9%, pain 12.9%, chronic 12.9%, community 9.68%, momentum 9.68%, ai 6.45%

Top accounts mentioned or mentioned by @aclarioncom @aclarioncomto @stocktwits @isassorg @northwesternmed @scrippshealth @rsna

Top assets mentioned Aclarion Inc. (ACON)

Top Social Posts

Top posts by engagements in the last [--] hours

"Were looking forward to Spine: Base to Summit and the thoughtful conversations this meeting always brings to the spine community. CEO Brent Ness will be available for 1:1 meetings. To discuss incorporating Nociscan into your practice please send us a message $ACON"
X Link 2026-01-14T15:00Z [---] followers, [---] engagements

"Looking forward to joining the spine community at #NASS2025 Connect with us at info@aclarion.com so we can discuss how Nociscan powered by MR Spectroscopy biomarkers and AI is helping physicians identify the source of chronic low back pain. See you in Denver $ACON"
X Link 2025-11-11T14:30Z [---] followers, [--] engagements

"Aclarion strengthens its balance sheet and extends cash runway into [----]. We are focused on expanding adoption of Nociscan deepening clinical evidence and building strategic relationships that drive durable growth for patients. Read more: $ACON https://bit.ly/3NjPqVV https://bit.ly/3NjPqVV"
X Link 2026-01-13T15:00Z [---] followers, [---] engagements

"We will be at the #SelbySpine Conference next week Looking forward to Dr. Nunleys presentation during the Tech Talks Session where he will be highlighting Nociscan and the value of MR Spectroscopy including his own patient examples. Connect with us at info@aclarion.com $ACON"
X Link 2026-01-29T16:00Z [---] followers, [--] engagements

"Were pleased to welcome Source Healthcare as the newest high-volume practice offering Nociscan in the greater Los Angeles area. This collaboration expands patient access and supports real-world evidence efforts led by Dr. Tim Davis. Read more: $ACON https://bit.ly/4rxHSOg https://bit.ly/4rxHSOg"
X Link 2026-02-03T15:00Z [---] followers, [--] engagements

"In an exclusive interview with @Stocktwits CEO Brent Ness outlines Aclarions [----] focus - advancing the CLARITY trial expanding real-world evidence UK coverage scanner access and reimbursement progress to drive adoption. Read more: $ACON https://bit.ly/3MqnBet https://bit.ly/3MqnBet"
X Link 2026-02-04T17:27Z [---] followers, [---] engagements

"Our [----] Shareholder Letter from Executive Chairman Jeff Thramann is live providing a detailed overview of Aclarion's progress key milestones and strategic priorities for [----]. Read the full update on our continued momentum and whats ahead: $ACON https://bit.ly/49YW90t https://bit.ly/49YW90t"
X Link 2026-02-05T14:45Z [---] followers, [---] engagements

"Nociscan turns MRI spectroscopy data into actionable insights using cloud-based AI. Aclarion CEO Brent Ness explains how it supports more informed clinical decision-making to improve outcomes for chronic low back pain on Empowered Patient Podcast: $ACON https://bit.ly/3Zt9BUm https://bit.ly/3Zt9BUm"
X Link 2026-02-10T20:19Z [---] followers, [--] engagements

"Chronic #lowbackpain is a life-changing condition that prevents many individuals from living full active lives. Patients around the world are already experiencing the benefits of #Nociscan. To learn more #ACON #ACONW #spine #nasdaq"
X Link 2023-06-29T20:51Z [--] followers, [--] engagements

"#ISASS24 is here Were excited to be at the conference this weekend. Reach out atinfo@aclarion.comto connect in Miami and learn more about how Nociscan can help you pinpoint the source of chronic #lowbackpain. #ACON #ACONW #nasdaq #spine #pain #spinesurgery"
X Link 2024-04-26T13:42Z [--] followers, [---] engagements

"Our first payer coverage decision for the Nociscan solution by AXA a leading provider of private medical insurance in the UK. Congrats to thephysicians at the London Clinicwhoworked to make this positive coverage decision possible #ACON #ACONW #nasdaq #smallcap #microcap"
X Link 2024-06-26T16:10Z [---] followers, [---] engagements

"Ready to learn how the #Nociscan solution can help improve treatment outcomes for patients suffering from chronic #owbackpain Join us at #ASPN Booth [---] to discover the latest clinical data on Nociscan #ACON #ACONW #nasdaq #ASPN2024 #ASPN24 #spine #spinesurgery"
X Link 2024-07-10T23:49Z [---] followers, [---] engagements

"Thank you for the invigorating discussion #ASPN2024 last week about the future of diagnosing chronic low back pain and the importance of solutions like #Nociscan in the driving the innovation needed to advance patient care. #ACON #ACONW #nasdaq #spinesurgery #lowbackpain"
X Link 2024-07-18T17:30Z [---] followers, [--] engagements

"Commitment to Clinical Evidence We are excited to announce the launch of our multi-center CLUE Trial to quantify how often Nociscans AI generated biomarker data changes surgical treatment plans. #ACON #ACONW #nasdaq #spinesurgery #lowbackpain https://aclarion.com/aclarion-launches-the-clinical-utility-and-economic-clue-trial/ https://aclarion.com/aclarion-launches-the-clinical-utility-and-economic-clue-trial/"
X Link 2024-08-21T14:56Z [---] followers, [---] engagements

"We are excited to announce our new partnership with Justin Kubeck MD and Ocean Pain and Spine to deliver Nociscan to patients in the personal injury and workers compensation market in Toms River NJ. #ACON #ACONW #nasdaq #lowbackpain #spinesurgery https://aclarion.com/aclarion-launches-surgeon-partnership-in-personal-injury-and-workers-compensation-market/ https://aclarion.com/aclarion-launches-surgeon-partnership-in-personal-injury-and-workers-compensation-market/"
X Link 2024-09-05T20:02Z [---] followers, [---] engagements

"Evidence. Growth. Access. To date in [----] we have already met many of our commercial goals toward our company mission of leading with clinical evidence to improve the care of cLBP. And year isn't done yet. #ACON #ACONW #nasdaq #spinesurgery #lowbackpain https://aclarion.com/aclarion-provides-corporate-update-on-nociscan-ai-technology-milestones/ https://aclarion.com/aclarion-provides-corporate-update-on-nociscan-ai-technology-milestones/"
X Link 2024-09-17T16:57Z [---] followers, [---] engagements

"Attending NASS this week Reach out atinfo@aclarion.comto meet with the Aclarion team in Chicago. #NASS2024 #ACON #ACONW #nasdaq #NASS24 #lowbackpain #spinesurgery"
X Link 2024-09-24T14:57Z [---] followers, [---] engagements

"At #ISSLS2024 researchers from the Reach Center at UCSF presented data where Nociscan AI was utilized to better understand Modic changes in patients suffering from chronic low back pain (cLBP). #ACON #ACONW #nasdaq #spinesurgery #ISSLS2024 https://aclarion.com/aclarions-nociscan-ai-plays-key-role-in-advanced-understanding-of-modic-changes/ https://aclarion.com/aclarions-nociscan-ai-plays-key-role-in-advanced-understanding-of-modic-changes/"
X Link 2024-09-27T22:37Z [---] followers, [---] engagements

"Great interview with Aclarion CEO Brent Ness and MedTech Guru Thomas Hickey about Nociscan and the key accomplishments that are driving Aclarions success. Listen today #ACON #ACONW #nasdaq #lowbackpain https://med-tech-gurus.libsyn.com/you-cant-see-pain https://med-tech-gurus.libsyn.com/you-cant-see-pain"
X Link 2024-10-11T13:32Z [---] followers, [----] engagements

"Integrating a disruptive technology into standard of care is difficult work but were doing it. $ACON CEO Brent Ness on building evidence reimbursement and adoption for Aclarions Nociscan platform. Full interview: #MedTech #A #Healthcare https://bit.ly/4oxpeox https://bit.ly/4oxpeox"
X Link 2025-11-13T14:15Z [---] followers, [--] engagements

"The $ACON team came together in Colorado for #NASS2025 and some team bonding. An incredible time of collaboration and connection as we gear up for an exciting year ahead. Heres to continued momentum meaningful collaboration and a strong finish to the year #TeamWork"
X Link 2025-11-17T18:30Z [---] followers, [--] engagements

"Check out CEO Brent Ness's latest interview on The Watchlist He highlights how Nociscan uses MR spectroscopy and biomarkers to give physicians the ability to "see the invisible" for chronic low back pain. Watch: $ACON #Healthcare #PainManagement https://bit.ly/4aeQeEV https://bit.ly/4aeQeEV"
X Link 2025-11-25T18:00Z [---] followers, [--] engagements

"Were proud to share that Nociscan is featured in the Special Pain Issue of the @ISASSorg. Being included is a meaningful acknowledgment of the momentum building for more objective tools to evaluate chronic low back pain. $ACON #PainManagement https://investors.aclarion.com/news/aclarion-announces-publication-of-nociscan-article-in-special-pain-issue-of-the-international-journal-of-spine-surgery-ijss https://investors.aclarion.com/news/aclarion-announces-publication-of-nociscan-article-in-special-pain-issue-of-the-international-journal-of-spine-surgery-ijss"
X Link 2025-12-04T14:07Z [---] followers, [---] engagements

"Were looking forward to the 19th NYC-MISS Symposium led by course directors Dr. Roger Hrtl and Dr. Luiz Pimenta If youll be attending and would like to connect reach out to us at info@aclarion.com. See you in NYC $ACON #NYCMISS"
X Link 2025-12-08T19:00Z [---] followers, [--] engagements

"Patient enrollment milestone - @NorthwesternMed and @ScrippsHealth have enrolled their first patients in the companys pivotal CLARITY trial also intended to support future reimbursement discussions. Read the press release: $ACON https://bit.ly/4sucYHA https://bit.ly/4sucYHA"
X Link 2026-01-06T17:57Z [---] followers, [---] engagements

"Aclarion provides an update on progress in [----] and outlook for [----]. We had an impressive year with significant NOCISCAN volume growth the launch of our pivotal CLARITY trial new hires to support commercial growth and more. Read the full release: $ACON https://bit.ly/4qc0rXN https://bit.ly/4qc0rXN"
X Link 2026-01-08T16:01Z [---] followers, [---] engagements

"Aclarion appoints Dan Isherwood as UK Commercial Director to drive adoption and market expansion in the UK - the first market worldwide where private insurers cover Nociscan - marking a key commercial milestone. Read more: $ACON #MedTech #Healthcare https://bit.ly/4hN2QF6 https://bit.ly/4hN2QF6"
X Link 2025-11-05T14:51Z [---] followers, [--] engagements

"Were looking forward to connecting with the global imaging community in Chicago for the Annual @RSNA Meeting. If youre attending #RSNA2025 reach out to info@aclarion.com to schedule a meeting with our CEO Brent Ness and CSO Ryan Bond. Hope to see you in Chicago $ACON"
X Link 2025-11-20T14:30Z [---] followers, [--] engagements

"Happy Thanksgiving from Aclarion As we reflect on the year were deeply grateful for the patients clinicians imaging partners and investors who believe in our mission to bring greater clarity to chronic low back pain. Wishing everyone a restorative holiday. $ACON"
X Link 2025-11-27T15:01Z [---] followers, [--] engagements

"Were excited to welcome Jason Brosniak as Aclarions new Commercial Director Eastern U.S. He joins at a pivotal time as we expand adoption of Nociscan and deepen payer engagement. Join us in welcoming him to the team $ACON #PainManagement https://bit.ly/44JyHkB https://bit.ly/44JyHkB"
X Link 2025-12-02T14:04Z [---] followers, [--] engagements

"✨ This year brought meaningful progress. As we look ahead we remain focused on advancing objective insights with Nociscan to help clinicians better understand chronic low back pain and support more personalized care. Wishing everyone a joyful holiday season"
X Link 2025-12-22T17:30Z [---] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing